TradingAgents AISign inGet started
All stock profiles
MCKNYSEHealthcare

MCKESSON CORP

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$1,060.84

-1.04%

Alpha Vantage · 11/6/2026

Industry: Medical DistributionCategory: Domestic Common StockCurrency: USDNews: 2 recent
Analyze MCK free

One-year price history

Adjusted daily closes · 252 observations · as of Nov 6, 2026

Historical data, not a forecast

1 month

+14.0%

3 months

+20.7%

6 months

+44.4%

1 year

+24.0%

Year to date

+29.7%

52-week range

$723.61 – $1,072.00

Fundamental snapshot

Latest reported period: Sep 30, 2026

Sharadar reported data

Market cap

$122.48B

P/E

26.1

P/B

-31

P/S

0.3

Revenue

$418.79B

Net income

$4.7B

Diluted EPS

38.83

Gross margin

3.70%

Net margin

1.10%

Return on equity

-161.20%

Total debt

$11.16B

Cash

$6.53B

Free cash flow

$6.87B

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Sep 30, 2026$110.96B$1.22B3.60%1.10%$2.95B
Jun 30, 2026$105.38B$614M3.50%0.60%-$372M
Mar 31, 2026$96.3B$1.68B4.20%1.70%$3.24B
Dec 31, 2025$106.16B$1.19B3.50%1.10%$1.06B
Sep 30, 2025$103.15B$1.11B3.40%1.10%$2.22B
Jun 30, 2025$97.83B$784M3.40%0.80%-$1.11B
Mar 31, 2025$90.82B$1.26B4.00%1.40%$7.47B
Dec 31, 2024$95.29B$879M3.40%0.90%-$2.58B

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent MCK news

All market news
TradingView·57 signal
Key facts: McKesson $3.1B Deal Financing; Analysts Raise Targets

McKesson Corporation and Clayton, Dubilier & Rice have secured $3.1 billion in financing from Wall Street banks for their acquisition of Option Care Health. Following this, five firms increased their price targets for McKesson, with the average 12-month target now at $1,122.71, suggesting a 5% upside from its November 4 close, while analysts maintained a consensus "Buy" rating.

Original source
HME News·73 signal
Option Care posts 4.1% increase for Q3, withdraws previous guidance

Option Care Health reported a 4.1% increase in net revenue for Q3 2026, reaching $1.493 billion, and an adjusted EBITDA increase of 4.3% to $124.6 million. The company has withdrawn its financial guidance and did not host an earnings call due to its pending acquisition by Clayton, Dubilier & Rice, LLC and McKesson Corporation.

Original source